On the public citation graph

Conformational Adaptation in Drug–Target Interactions and Residence Time

0 signed · 262 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/0471220639openalex-snapshot
Enzymes
inferredcites →https://doi.org/10.1002/9780470123072.ch5openalex-snapshot
The Behavior and Significance of Slow‐Binding Enzyme Inhibitors
inferredcites →https://doi.org/10.1002/cber.189002302157openalex-snapshot
Ueber die optischen Isomeren des Traubenzuckers, der Gluconsäure und der Zuckersäure
inferredcites →https://doi.org/10.1002/prot.22223openalex-snapshot
Selected‐fit versus induced‐fit protein binding: Kinetic differences and mutational analysis
inferredcites →https://doi.org/10.1006/abbi.1998.0739openalex-snapshot
Competitive and Slow-Binding Inhibition of Calcineurin by Drug · Immunophilin Complexes
inferredcites →https://doi.org/10.1006/jmbi.1995.0310openalex-snapshot
Slow ligand-induced transitions in the allosteric phosphofructokinase from Escherichia coli
inferredcites →https://doi.org/10.1006/jmbi.2000.3858openalex-snapshot
The crystal structure of tetrameric methionine adenosyltransferase from rat liver reveals the methionine-binding site 1 1Edited by R. Huber
inferredcites →https://doi.org/10.1016/0006-2952(75)90050-7openalex-snapshot
Tight-binding inhibitors—I
inferredcites →https://doi.org/10.1016/0006-2952(75)90051-9openalex-snapshot
Tight-binding inhibitors—II
inferredcites →https://doi.org/10.1016/0022-2836(71)90294-4openalex-snapshot
Equilibrium and rate constants for the interconversion of two conformations of α-chymotrypsin
inferredcites →https://doi.org/10.1016/0167-4838(92)90063-jopenalex-snapshot
Relaxation kinetics of ribonuclease T1 binding with guanosine and 3′-GMP
inferredcites →https://doi.org/10.1016/j.abb.2003.11.013openalex-snapshot
Hepatitis C NS3 protease inhibition by peptidyl-α-ketoamide inhibitors: kinetic mechanism and structure
inferredcites →https://doi.org/10.1016/j.cbpa.2010.06.176openalex-snapshot
Drug–target residence time: critical information for lead optimization
inferredcites →https://doi.org/10.1016/j.ceb.2009.01.012openalex-snapshot
Structural biology contributions to tyrosine kinase drug discovery
inferredcites →https://doi.org/10.1016/j.drudis.2008.12.011openalex-snapshot
Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations
inferredcites →https://doi.org/10.1016/j.tips.2006.05.001openalex-snapshot
Slow antagonist dissociation and long-lasting in vivo receptor protection
inferredcites →https://doi.org/10.1016/s0021-9258(18)94433-9openalex-snapshot
Escherichia coli Alkaline Phosphatase
inferredcites →https://doi.org/10.1016/s0167-4838(01)00248-5openalex-snapshot
The inactivation of lipoxygenase-1 from soybeans by amidrazones
inferredcites →https://doi.org/10.1021/bi00579a021openalex-snapshot
Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase
inferredcites →https://doi.org/10.1021/bi010584xopenalex-snapshot
Purine Nucleoside Phosphorylase from Mycobacterium tuberculosis. Analysis of Inhibition by a Transition-State Analogue and Dissection by Parts
inferredcites →https://doi.org/10.1021/bi012126uopenalex-snapshot
Mutagenesis and Mechanism-Based Inhibition of Streptococcus pyogenes Glu-tRNAGln Amidotransferase Implicate a Serine-Based Glutaminase Site
inferredcites →https://doi.org/10.1021/bi026318gopenalex-snapshot
Aminophosphonate Inhibitors of Dialkylglycine Decarboxylase: Structural Basis for Slow Binding Inhibition,
inferredcites →https://doi.org/10.1021/bi048632bopenalex-snapshot
Mechanism of Time-Dependent Inhibition of Polypeptide Deformylase by Actinonin
inferredcites →https://doi.org/10.1021/bi0518186openalex-snapshot
A Slow, Tight-Binding Inhibitor of the Zinc-Dependent Deacetylase LpxC of Lipid A Biosynthesis with Antibiotic Activity Comparable to Ciprofloxacin
inferredcites →https://doi.org/10.1021/bi0617308openalex-snapshot
A Pre-Steady State Analysis of Ligand Binding to Human Glucokinase: Evidence for a Preexisting Equilibrium
inferredcites →https://doi.org/10.1021/bi7011355openalex-snapshot
Binding of TPX2 to Aurora A Alters Substrate and Inhibitor Interactions
inferredcites →https://doi.org/10.1021/bi702061gopenalex-snapshot
Mechanism of Inhibition of Human KSP by Ispinesib
inferredcites →https://doi.org/10.1021/bi8002023openalex-snapshot
Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
inferredcites →https://doi.org/10.1021/bi801883vopenalex-snapshot
Pseudoirreversible Inhibition of Prostate-Specific Membrane Antigen by Phosphoramidate Peptidomimetics
inferredcites →https://doi.org/10.1021/bi802141yopenalex-snapshot
Potent Inhibitors of HIV-1 Integrase Display a Two-Step, Slow-Binding Inhibition Mechanism Which Is Absent in a Drug-Resistant T66I/M154I Mutant
inferredcites →https://doi.org/10.1021/bi900038popenalex-snapshot
Inhibition and Binding Kinetics of the Hepatitis C Virus NS3 Protease Inhibitor ITMN-191 Reveals Tight Binding and Slow Dissociative Behavior
inferredcites →https://doi.org/10.1021/bi901579yopenalex-snapshot
Efavirenz Binding to HIV-1 Reverse Transcriptase Monomers and Dimers
inferredcites →https://doi.org/10.1038/nchembio.232openalex-snapshot
The role of dynamic conformational ensembles in biomolecular recognition
inferredcites →https://doi.org/10.1038/nchembio.452openalex-snapshot
Dynamics connect substrate recognition to catalysis in protein kinase A
inferredcites →https://doi.org/10.1038/nrd1500openalex-snapshot
Biochemical mechanisms of drug action: what does it take for success?
inferredcites →https://doi.org/10.1038/nrd2082openalex-snapshot
Drug–target residence time and its implications for lead optimization
inferredcites →https://doi.org/10.1038/nsb770openalex-snapshot
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
inferredcites →https://doi.org/10.1042/bj1250319openalex-snapshot
Escherichia coli alkaline phosphatase. An analysis of transient kinetics
inferredcites →https://doi.org/10.1042/bj1650061openalex-snapshot
Kinetic evidence for a ‘mnemonical’ mechanism for rat liver glucokinase
inferredcites →https://doi.org/10.1042/bj20040228openalex-snapshot
Kinetic and structural analysis of the increased affinity of enoyl-ACP (acyl-carrier protein) reductase for triclosan in the presence of NAD+
inferredcites →https://doi.org/10.1042/bj20090121openalex-snapshot
Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B and Aurora C kinases with an extremely long residence time1
inferredcites →https://doi.org/10.1042/bst0310528openalex-snapshot
Molecular mechanism for inhibition of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase by rosuvastatin
inferredcites →https://doi.org/10.1073/pnas.0602650103openalex-snapshot
A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analogues
inferredcites →https://doi.org/10.1073/pnas.0700041104openalex-snapshot
Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity
inferredcites →https://doi.org/10.1073/pnas.0805364105openalex-snapshot
Enzymes with lid-gated active sites must operate by an induced fit mechanism instead of conformational selection
inferredcites →https://doi.org/10.1073/pnas.0907195106openalex-snapshot
Conformational selection or induced fit: A flux description of reaction mechanism
inferredcites →https://doi.org/10.1073/pnas.2235848100openalex-snapshot
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance
inferredcites →https://doi.org/10.1073/pnas.91.23.11202openalex-snapshot
Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.
inferredcites →https://doi.org/10.1074/jbc.271.7.3548openalex-snapshot
The Kinetic Factors That Determine the Affinity and Selectivity for Slow Binding Inhibition of Human Prostaglandin H Synthase 1 and 2 by Indomethacin and Flurbiprofen
inferredcites →https://doi.org/10.1074/jbc.272.8.4959openalex-snapshot
1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo
inferredcites →https://doi.org/10.1074/jbc.m101896200openalex-snapshot
Mechanism of Inhibition of β-Site Amyloid Precursor Protein-cleaving Enzyme (BACE) by a Statine-based Peptide
inferredcites →https://doi.org/10.1074/jbc.m109.077909openalex-snapshot
Slow Onset Inhibition of Bacterial β-Ketoacyl-acyl Carrier Protein Synthases by Thiolactomycin
inferredcites →https://doi.org/10.1074/jbc.m111250200openalex-snapshot
Slow-Tight Binding Inhibition of Xylanase by an Aspartic Protease Inhibitor
inferredcites →https://doi.org/10.1074/jbc.m203120200openalex-snapshot
Novel Inhibition of Porcine Pepsin by a Substituted Piperidine
inferredcites →https://doi.org/10.1074/jbc.m305493200openalex-snapshot
The Relationship between Side Reactions and Slow Inhibition of Ribulose-bisphosphate Carboxylase Revealed by a Loop 6 Mutant of the Tobacco Enzyme
inferredcites →https://doi.org/10.1111/j.1476-5381.2009.00604.xopenalex-snapshot
Ligand binding assays at equilibrium: validation and interpretation
inferredcites →https://doi.org/10.1126/science.1198542openalex-snapshot
A Dynamic Knockout Reveals That Conformational Fluctuations Influence the Chemical Step of Enzyme Catalysis
inferredcites →https://doi.org/10.1126/science.1273579openalex-snapshot
Tunneling in Ligand Binding to Heme Proteins
inferredcites →https://doi.org/10.1128/aac.50.3.899-909.2006openalex-snapshot
Preclinical Profile of VX-950, a Potent, Selective, and Orally Bioavailable Inhibitor of Hepatitis C Virus NS3-4A Serine Protease
inferredcites →https://doi.org/10.1128/jvi.01184-07openalex-snapshot
Binding Kinetics of Darunavir to Human Immunodeficiency Virus Type 1 Protease Explain the Potent Antiviral Activity and High Genetic Barrier
inferredcites →https://doi.org/10.1158/0008-5472.can-04-1168openalex-snapshot
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
inferredcites →https://doi.org/10.1158/0008-5472.can-07-5783openalex-snapshot
Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
inferredcites →https://doi.org/10.1517/17460441003677725openalex-snapshot
The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety
inferredcites →https://doi.org/10.2174/156802606776743101openalex-snapshot
Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor
inferredcites →https://doi.org/10.2174/187231310790226215openalex-snapshot
Structural Mechanisms of Slow-Onset, Two-Step Enzyme Inhibition
inferredcites →https://doi.org/10.5860/choice.38-3881openalex-snapshot
Enzymes: a practical introduction to structure, mechanism, and data analysis

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/9781118354483.ch3openalex-snapshot
In VitroandIn VivoAssays
inferred← citeshttps://doi.org/10.1002/9781118540398.ch8openalex-snapshot
Drug–Target Residence Time
inferred← citeshttps://doi.org/10.1002/9781118573983.ch4openalex-snapshot
Molecular Modeling of Block Copolymer Self‐Assembly and Micellar Drug Delivery
inferred← citeshttps://doi.org/10.1002/9781118681121.ch4openalex-snapshot
Fragment‐Based Ligand Discovery
inferred← citeshttps://doi.org/10.1002/9781119793304.ch4openalex-snapshot
PROTEIN–LIGAND BINDING EQUILIBRIA
inferred← citeshttps://doi.org/10.1002/9783527673025.ch10openalex-snapshot
Challenges in the Medicinal Chemical Optimization of Binding Kinetics
inferred← citeshttps://doi.org/10.1002/9783527673025.ch12openalex-snapshot
The Use of Structural Information to Understand Binding Kinetics
inferred← citeshttps://doi.org/10.1002/9783527673025.ch8openalex-snapshot
Drug–Target Residence Time
inferred← citeshttps://doi.org/10.1002/9783527673025.ch9openalex-snapshot
Experimental Methods to Determine Binding Kinetics
inferred← citeshttps://doi.org/10.1002/9783527687503.ch2openalex-snapshot
FLiK and FLiP: Direct Binding Assays for the Identification of Stabilizers of Inactive Kinase and Phosphatase Conformations
inferred← citeshttps://doi.org/10.1002/ange.201409779openalex-snapshot
Ligand‐Detected Relaxation Dispersion NMR Spectroscopy: Dynamics of preQ1–RNA Binding
inferred← citeshttps://doi.org/10.1002/ange.201509997openalex-snapshot
SAM‐II Riboswitch Samples at least Two Conformations in Solution in the Absence of Ligand: Implications for Recognition
inferred← citeshttps://doi.org/10.1002/ange.201802603openalex-snapshot
Zeitaufgelöst und markerfrei gemessene ligandeninduzierte Konformationsänderungen von HSP90 – hin zu einem Konformationsaktivitätsscreening für die Wirkstoffentwicklung
inferred← citeshttps://doi.org/10.1002/anie.201409779openalex-snapshot
Ligand‐Detected Relaxation Dispersion NMR Spectroscopy: Dynamics of preQ1–RNA Binding
inferred← citeshttps://doi.org/10.1002/anie.201509997openalex-snapshot
SAM‐II Riboswitch Samples at least Two Conformations in Solution in the Absence of Ligand: Implications for Recognition
inferred← citeshttps://doi.org/10.1002/anie.201802603openalex-snapshot
Ligand‐Induced Conformational Changes in HSP90 Monitored Time Resolved and Label Free—Towards a Conformational Activity Screening for Drug Discovery
inferred← citeshttps://doi.org/10.1002/cbic.201300613openalex-snapshot
Long Residence Times Revealed by Aurora A Kinase‐Targeting Fluorescent Probes Derived from Inhibitors MLN8237 and VX‐689
inferred← citeshttps://doi.org/10.1002/cbic.201600697openalex-snapshot
Slowly on, Slowly off: Bisubstrate‐Analogue Conjugates of 5‐Iodotubercidin and Histone H3 Peptide Targeting Protein Kinase Haspin
inferred← citeshttps://doi.org/10.1002/cbic.201900527openalex-snapshot
Validation of the Slow Off‐Kinetics of Sirtuin‐Rearranging Ligands (SirReals) by Means of Label‐Free Electrically Switchable Nanolever Technology
inferred← citeshttps://doi.org/10.1002/cmdc.201402521openalex-snapshot
The Use of Thermodynamic and Kinetic Data in Drug Discovery: Decisive Insight or Increasing the Puzzlement?
inferred← citeshttps://doi.org/10.1002/jcb.28461openalex-snapshot
Molecular interaction of investigational ligands with human brain acetylcholinesterase
inferred← citeshttps://doi.org/10.1002/jcc.25201openalex-snapshot
Steered molecular dynamics simulations for uncovering the molecular mechanisms of drug dissociation and for drug screening: A test on the focal adhesion kinase
inferred← citeshttps://doi.org/10.1002/jmr.2618openalex-snapshot
Conformational energy range of ligands in protein crystal structures: The difficult quest for accurate understanding
inferred← citeshttps://doi.org/10.1002/med.21307openalex-snapshot
Drug‐Target Residence Time—A Case for G Protein‐Coupled Receptors
inferred← citeshttps://doi.org/10.1002/prot.24123openalex-snapshot
Conformational selection and induced changes along the catalytic cycle of Escherichia coli dihydrofolate reductase
inferred← citeshttps://doi.org/10.1002/prp2.847openalex-snapshot
Induced fit versus conformational selection: From rate constants to fluxes… and back to rate constants
inferred← citeshttps://doi.org/10.1007/978-1-4614-7931-4_13openalex-snapshot
Targeting Chromatin Modifying Enzymes in Anticancer Drug Discovery
inferred← citeshttps://doi.org/10.1007/978-1-4939-7756-7_20openalex-snapshot
Enhanced Molecular Dynamics Methods Applied to Drug Design Projects
inferred← citeshttps://doi.org/10.1007/978-981-15-8936-2_5openalex-snapshot
Protein Structure, Dynamics and Assembly: Implications for Drug Discovery
inferred← citeshttps://doi.org/10.1007/s00210-013-0881-0openalex-snapshot
Simplified models for heterobivalent ligand binding: when are they applicable and which are the factors that affect their target residence time
inferred← citeshttps://doi.org/10.1007/s00210-017-1362-7openalex-snapshot
Competitive association binding kinetic assays: a new tool to detect two different binding orientations of a ligand to its target protein under distinct conditions?
inferred← citeshttps://doi.org/10.1007/s00249-015-1090-1openalex-snapshot
Discrimination between conformational selection and induced fit protein–ligand binding using Integrated Global Fit analysis
inferred← citeshttps://doi.org/10.1007/s00894-024-05962-9openalex-snapshot
Efficient molecular conformation generation with quantum-inspired algorithm
inferred← citeshttps://doi.org/10.1007/s10928-026-10049-4openalex-snapshot
Ehrlich occupancy time: beyond $$k_\textrm{off}$$ to a complete residence time framework
inferred← citeshttps://doi.org/10.1007/s12010-021-03718-2openalex-snapshot
Screening and Identification of Potential iNOS Inhibitors to Curtail Cervical Cancer Progression: an In Silico Drug Repurposing Approach
inferred← citeshttps://doi.org/10.1007/s12010-023-04541-7openalex-snapshot
Entrectinib a Plausible Inhibitor for Osteopontin (SPP1) in Cervical Cancer—Integrated Bioinformatic Approach
inferred← citeshttps://doi.org/10.1016/b978-0-12-397918-6.00006-9openalex-snapshot
FLiK
inferred← citeshttps://doi.org/10.1016/bs.armc.2022.08.006openalex-snapshot
No dance, no partner! A tale of receptor flexibility in docking and virtual screening
inferred← citeshttps://doi.org/10.1016/j.abb.2016.02.010openalex-snapshot
Slow-binding inhibition of cholinesterases, pharmacological and toxicological relevance
inferred← citeshttps://doi.org/10.1016/j.bbapap.2013.01.027openalex-snapshot
How conformational changes can affect catalysis, inhibition and drug resistance of enzymes with induced-fit binding mechanism such as the HIV-1 protease
inferred← citeshttps://doi.org/10.1016/j.bcp.2013.09.007openalex-snapshot
Pharmacokinetics
inferred← citeshttps://doi.org/10.1016/j.bmcl.2014.04.001openalex-snapshot
Optimization of ketone-based P2Y12 receptor antagonists as antithrombotic agents: Pharmacodynamics and receptor kinetics considerations
inferred← citeshttps://doi.org/10.1016/j.bmcl.2014.08.028openalex-snapshot
Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists III: The role of a hydrogen-bond acceptor in long receptor residence times
inferred← citeshttps://doi.org/10.1016/j.bmcl.2014.08.029openalex-snapshot
Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists II: Lead optimization
inferred← citeshttps://doi.org/10.1016/j.bmcl.2014.09.005openalex-snapshot
Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists I
inferred← citeshttps://doi.org/10.1016/j.bmcl.2015.02.027openalex-snapshot
Design strategies to address kinetics of drug binding and residence time
inferred← citeshttps://doi.org/10.1016/j.celrep.2015.12.010openalex-snapshot
Conformational Selection in a Protein-Protein Interaction Revealed by Dynamic Pathway Analysis
inferred← citeshttps://doi.org/10.1016/j.chembiol.2021.07.018openalex-snapshot
Development of an intracellular quantitative assay to measure compound binding kinetics
inferred← citeshttps://doi.org/10.1016/j.coph.2016.07.004openalex-snapshot
Impact, determination and prediction of drug–receptor residence times for GPCRs
inferred← citeshttps://doi.org/10.1016/j.ddtec.2015.08.003openalex-snapshot
On-rate based optimization of structure–kinetic relationship – surfing the kinetic map
inferred← citeshttps://doi.org/10.1016/j.ddtec.2015.09.001openalex-snapshot
Radioligand binding to intact cells as a tool for extended drug screening in a representative physiological context
inferred← citeshttps://doi.org/10.1016/j.ddtec.2015.09.003openalex-snapshot
Kinetic analysis of drug–protein interactions by affinity chromatography
inferred← citeshttps://doi.org/10.1016/j.drudis.2013.02.007openalex-snapshot
Molecular determinants of drug–receptor binding kinetics
inferred← citeshttps://doi.org/10.1016/j.drudis.2013.02.010openalex-snapshot
Pharmacokinetics and the drug–target residence time concept
inferred← citeshttps://doi.org/10.1016/j.drudis.2017.02.002openalex-snapshot
Kinetics for Drug Discovery: an industry-driven effort to target drug residence time
inferred← citeshttps://doi.org/10.1016/j.ejmcr.2025.100320openalex-snapshot
Exploiting the synergy between computational and experimental biophysics for efficient cancer drug development
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112924openalex-snapshot
An update into the medicinal chemistry of translocator protein (TSPO) ligands
inferred← citeshttps://doi.org/10.1016/j.ejphar.2017.01.040openalex-snapshot
Characterization of ligand binding to melanocortin 4 receptors using fluorescent peptides with improved kinetic properties
inferred← citeshttps://doi.org/10.1016/j.ejphar.2017.11.043openalex-snapshot
Abediterol (LAS100977), an inhaled long-acting β 2 -adrenoceptor agonist, has a fast association rate and long residence time at receptor
inferred← citeshttps://doi.org/10.1016/j.envpol.2015.12.051openalex-snapshot
The first toxicological study of the antiozonant and research tool ethylene diurea (EDU) using a Lemna minor L. bioassay: Hints to its mode of action
inferred← citeshttps://doi.org/10.1016/j.insi.2026.100535openalex-snapshot
Molecular docking and molecular dynamic simulation analyses unveil pimara-8(14),15-diene, a phytometabolite of Nigella sativa as a putative binder of SARS-CoV-2 key proteins
inferred← citeshttps://doi.org/10.1016/j.jmb.2016.12.019openalex-snapshot
Compound Selectivity and Target Residence Time of Kinase Inhibitors Studied with Surface Plasmon Resonance
inferred← citeshttps://doi.org/10.1016/j.jmgm.2020.107730openalex-snapshot
Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2–P3 α-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach
inferred← citeshttps://doi.org/10.1016/j.molstruc.2020.129633openalex-snapshot
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome
inferred← citeshttps://doi.org/10.1016/j.molstruc.2023.134903openalex-snapshot
DFT-aided infrared and electronic circular dichroism spectroscopic study of cyclopeptide S-PK6 and the exploration of its antitumor potential by molecular docking
inferred← citeshttps://doi.org/10.1016/j.molstruc.2023.135894openalex-snapshot
Photo-induced synthesis, stereochemistry and antitumor activity of natural cyclopeptide Hikiamide B analogs
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2020.108236openalex-snapshot
Slow-binding inhibitors of acetylcholinesterase of medical interest
inferred← citeshttps://doi.org/10.1016/j.phrs.2015.10.021openalex-snapshot
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
inferred← citeshttps://doi.org/10.1016/j.phrs.2021.105880openalex-snapshot
Unraveling binding mechanism and kinetics of macrocyclic Gαq protein inhibitors
inferred← citeshttps://doi.org/10.1016/j.sbi.2025.103214openalex-snapshot
Drug–target residence time: Analyzing cooperativity effects in G protein-coupled receptors by mathematical modeling and molecular dynamics simulations
inferred← citeshttps://doi.org/10.1016/j.tibs.2019.04.004openalex-snapshot
Drug–Target Association Kinetics in Drug Discovery
inferred← citeshttps://doi.org/10.1016/j.tips.2020.10.003openalex-snapshot
Fluxes for Unraveling Complex Binding Mechanisms
inferred← citeshttps://doi.org/10.1016/j.trac.2026.119089openalex-snapshot
From affinity to kinetics: SPR as the analytical backbone of AI-driven drug discovery
inferred← citeshttps://doi.org/10.1021/acs.accounts.5b00516openalex-snapshot
Protein Binding Pocket Dynamics
inferred← citeshttps://doi.org/10.1021/acs.biochem.1c00294openalex-snapshot
Potent Phenylpyridine and Oxodihydrofuran Inhibitors of Cyclooxygenase-2: Optimization toward a Long Residence Time with Balanced Internal Energetics
inferred← citeshttps://doi.org/10.1021/acs.biochem.6b01048openalex-snapshot
Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase
inferred← citeshttps://doi.org/10.1021/acs.biochem.8b00231openalex-snapshot
Slow-Binding Inhibition of Mycobacterium tuberculosis Shikimate Kinase by Manzamine Alkaloids
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.2c00446openalex-snapshot
Click Chemistry-Enabled Conjugation Strategy for Producing Dibenzodiazepinone-Type Fluorescent Probes To Target M2Acetylcholine Receptors
inferred← citeshttps://doi.org/10.1021/acs.cgd.4c01683openalex-snapshot
MicroED Structures of Fluticasone Furoate and Fluticasone Propionate Provide New Insights into Their Function
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c00852openalex-snapshot
Estimation of Drug-Target Residence Time by Targeted Molecular Dynamics Simulations
inferred← citeshttps://doi.org/10.1021/acs.jcim.5b00632openalex-snapshot
Toward High-Throughput Predictive Modeling of Protein Binding/Unbinding Kinetics
inferred← citeshttps://doi.org/10.1021/acs.jctc.1c00649openalex-snapshot
Enhanced Sampling Approach to the Induced-Fit Docking Problem in Protein–Ligand Binding: The Case of Mono-ADP-Ribosylation Hydrolase Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.jctc.9b00104openalex-snapshot
Investigating Drug–Target Residence Time in Kinases through Enhanced Sampling Simulations
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00708openalex-snapshot
Large-Scale Ligand Perturbations of the Protein Conformational Landscape Reveal State-Specific Interaction Hotspots
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c01160openalex-snapshot
Evolution of Slow-Binding Inhibitors Targeting Histone Deacetylase Isoforms
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c01224openalex-snapshot
[ 3 H]UR-JG102–A Radiolabeled Cyclic Peptide with High Affinity and Excellent Selectivity for the Neuropeptide Y Y 4 Receptor
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c02299openalex-snapshot
Innovative Medicinal Chemistry Strategies for Improving Target Binding Kinetics in Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b00475openalex-snapshot
Comparative Analysis of Binding Kinetics and Thermodynamics of Dipeptidyl Peptidase-4 Inhibitors and Their Relationship to Structure
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b01892openalex-snapshot
Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M 2 Muscarinic Acetylcholine Receptor
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b00941openalex-snapshot
Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH)
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b00080openalex-snapshot
Ligand Desolvation Steers On-Rate and Impacts Drug Residence Time of Heat Shock Protein 90 (Hsp90) Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b02172openalex-snapshot
Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M2 Receptor
inferred← citeshttps://doi.org/10.1021/acschembio.6b00979openalex-snapshot
Elucidating the Origin of Long Residence Time Binding for Inhibitors of the Metalloprotease Thermolysin
inferred← citeshttps://doi.org/10.1021/acschemneuro.7b00185openalex-snapshot
Drug–Target Kinetics in Drug Discovery
inferred← citeshttps://doi.org/10.1021/acsinfecdis.2c00073openalex-snapshot
A Target Engagement Assay to Assess Uptake, Potency, and Retention of Antibiotics in Living Bacteria
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.5b00474openalex-snapshot
Cathepsin B Inhibitors: Combining Dipeptide Nitriles with an Occluding Loop Recognition Element by Click Chemistry
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.8b00397openalex-snapshot
Prediction of Drug–Target Binding Kinetics by Comparative Binding Energy Analysis
inferred← citeshttps://doi.org/10.1021/acsomega.7b01085openalex-snapshot
Heterodimerization of Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Leads to Increased M2R Affinity and Selectivity
inferred← citeshttps://doi.org/10.1021/acsptsci.0c00012openalex-snapshot
Perspective: Implications of Ligand–Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors
inferred← citeshttps://doi.org/10.1021/acsptsci.4c00013openalex-snapshot
Illuminating Neuropeptide Y Y4 Receptor Binding: Fluorescent Cyclic Peptides with Subnanomolar Binding Affinity as Novel Molecular Tools
inferred← citeshttps://doi.org/10.1021/bc400246zopenalex-snapshot
Fab-PEG-Fab as a Potential Antibody Mimetic
inferred← citeshttps://doi.org/10.1021/bi300620copenalex-snapshot
Insights into the Inhibition of the p90 Ribosomal S6 Kinase (RSK) by the Flavonol Glycoside SL0101 from the 1.5 Å Crystal Structure of the N-Terminal Domain of RSK2 with Bound Inhibitor
inferred← citeshttps://doi.org/10.1021/bi400413copenalex-snapshot
Rational Optimization of Drug-Target Residence Time: Insights from Inhibitor Binding to the Staphylococcus aureus FabI Enzyme–Product Complex
inferred← citeshttps://doi.org/10.1021/bi501101vopenalex-snapshot
Slow Inhibition and Conformation Selective Properties of Extracellular Signal-Regulated Kinase 1 and 2 Inhibitors
inferred← citeshttps://doi.org/10.1021/cb4008748openalex-snapshot
Long Residence Time Inhibition of EZH2 in Activated Polycomb Repressive Complex 2
inferred← citeshttps://doi.org/10.1021/cb400896gopenalex-snapshot
A Structural and Energetic Model for the Slow-Onset Inhibition of the Mycobacterium tuberculosis Enoyl-ACP Reductase InhA
inferred← citeshttps://doi.org/10.1021/cb500235nopenalex-snapshot
Chemoproteomics Reveals Time-Dependent Binding of Histone Deacetylase Inhibitors to Endogenous Repressor Complexes
inferred← citeshttps://doi.org/10.1021/ci4001458openalex-snapshot
Water Network Perturbation in Ligand Binding: Adenosine A2AAntagonists as a Case Study
inferred← citeshttps://doi.org/10.1021/ja504810zopenalex-snapshot
Systems Biology Brings New Dimensions for Structure-Based Drug Design
inferred← citeshttps://doi.org/10.1021/jacs.3c08940openalex-snapshot
How Robust Is the Ligand Binding Transition State?
inferred← citeshttps://doi.org/10.1021/jacs.3c11856openalex-snapshot
De Novo Discovery of Cysteine Frameworks for Developing Multicyclic Peptide Libraries for Ligand Discovery
inferred← citeshttps://doi.org/10.1021/jacs.4c08597openalex-snapshot
Programming the Kinetics of Chemical Communication: Induced Fit vs Conformational Selection
inferred← citeshttps://doi.org/10.1021/jm4004076openalex-snapshot
Targeting Gain of Function and Resistance Mutations in Abl and KIT by Hybrid Compound Design
inferred← citeshttps://doi.org/10.1021/jm401219yopenalex-snapshot
Molecular Basis for the Long Duration of Action and Kinetic Selectivity of Tiotropium for the Muscarinic M3 Receptor
inferred← citeshttps://doi.org/10.1021/jm401690fopenalex-snapshot
Identification of Weak Points of Hepatitis C Virus NS3 Protease Inhibitors Using Surface Plasmon Resonance Biosensor-Based Interaction Kinetic Analysis and Genetic Variants
inferred← citeshttps://doi.org/10.1021/jm500167qopenalex-snapshot
Identification of Type II and III DDR2 Inhibitors
inferred← citeshttps://doi.org/10.1021/jm500505fopenalex-snapshot
Targeting Matrix Metalloproteinases: Exploring the Dynamics of the S1′ Pocket in the Design of Selective, Small Molecule Inhibitors
inferred← citeshttps://doi.org/10.1021/ml400160aopenalex-snapshot
Discovery of Novel Insulin-Like Growth Factor-1 Receptor Inhibitors with Unique Time-Dependent Binding Kinetics
inferred← citeshttps://doi.org/10.1038/ncomms2304openalex-snapshot
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
inferred← citeshttps://doi.org/10.1038/nmeth.3139openalex-snapshot
Time-resolved crystallography using the Hadamard transform
inferred← citeshttps://doi.org/10.1038/nrd.2015.18openalex-snapshot
The drug–target residence time model: a 10-year retrospective
inferred← citeshttps://doi.org/10.1038/onc.2012.552openalex-snapshot
Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics
inferred← citeshttps://doi.org/10.1038/s41429-024-00769-5openalex-snapshot
The effect of novel β-lactam derivatives synthesized from substituted phenethylamines on resistance genes of MRSA isolates
inferred← citeshttps://doi.org/10.1038/s41467-017-02258-wopenalex-snapshot
Protein conformational flexibility modulates kinetics and thermodynamics of drug binding
inferred← citeshttps://doi.org/10.1038/s41598-019-47298-yopenalex-snapshot
A Variable Neighbourhood Descent Heuristic for Conformational Search Using a Quantum Annealer
inferred← citeshttps://doi.org/10.1038/s41598-020-73822-6openalex-snapshot
Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning
inferred← citeshttps://doi.org/10.1038/srep18164openalex-snapshot
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy
inferred← citeshttps://doi.org/10.1039/c3mb25471bopenalex-snapshot
A comprehensive analysis of the influence of drug binding kinetics on drug action at molecular and systems levels
inferred← citeshttps://doi.org/10.1039/c6mb00595kopenalex-snapshot
Effect of small molecules on cell reprogramming
inferred← citeshttps://doi.org/10.1039/c6md00581kopenalex-snapshot
Protein–ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling
inferred← citeshttps://doi.org/10.1039/c6sc01000hopenalex-snapshot
Correlating drug–target kinetics and in vivo pharmacodynamics: long residence time inhibitors of the FabI enoyl-ACP reductase
inferred← citeshttps://doi.org/10.1039/c8md00296gopenalex-snapshot
Link between a high k on for drug binding and a fast clinical action: to be or not to be?
inferred← citeshttps://doi.org/10.1039/d0cs01084gopenalex-snapshot
Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses
inferred← citeshttps://doi.org/10.1039/d3cp03372dopenalex-snapshot
Simulation of the ligand-leaving process of the human heat shock protein
inferred← citeshttps://doi.org/10.1039/d3nj05320bopenalex-snapshot
Design, synthesis, and anti-tumor activity of cyclic peptide–lenalidomide conjugated small molecules
inferred← citeshttps://doi.org/10.1039/d3sc04195fopenalex-snapshot
QMrebind: incorporating quantum mechanical force field reparameterization at the ligand binding site for improved drug-target kinetics through milestoning simulations
inferred← citeshttps://doi.org/10.1042/bj20120499openalex-snapshot
Definition of the binding mode of a new class of phosphoinositide 3-kinase α-selective inhibitors using in vitro mutagenesis of non-conserved amino acids and kinetic analysis
inferred← citeshttps://doi.org/10.1080/07391102.2019.1707121openalex-snapshot
Deciphering molecular mechanism behind conformational change of the São Paolo metallo-β-lactamase 1 by using enhanced sampling
inferred← citeshttps://doi.org/10.1080/07391102.2024.2426078openalex-snapshot
Binding kinetics of highly mutated HIV-1 subtype C protease inhibition by Lopinavir and Darunavir in the face of altered conformational dynamics
inferred← citeshttps://doi.org/10.1080/08927022.2014.890722openalex-snapshot
Molecular simulation of drug-binding kinetics
inferred← citeshttps://doi.org/10.1080/17460441.2017.1245721openalex-snapshot
High performance enzyme kinetics of turnover, activation and inhibition for translational drug discovery
inferred← citeshttps://doi.org/10.1089/adt.2015.649openalex-snapshot
Development of a Surface Plasmon Resonance Assay for the Characterization of Small-Molecule Binding Kinetics and Mechanism of Binding to Kynurenine 3-Monooxygenase
inferred← citeshttps://doi.org/10.1093/database/baz101openalex-snapshot
KOFFI and Anabel 2.0—a new binding kinetics database and its integration in an open-source binding analysis software
inferred← citeshttps://doi.org/10.1101/2023.06.29.547035openalex-snapshot
Competition between induced fit- and conformational selection binding: how different flux-based approaches help clarifying their interplay
inferred← citeshttps://doi.org/10.1101/2024.09.18.613782openalex-snapshot
MicroED Structures of Fluticasone Furoate and Fluticasone Propionate Provide New Insights to Their Function
inferred← citeshttps://doi.org/10.1101/510255openalex-snapshot
Structure-Unbinding Kinetics Relationship of p38α MAPK Inhibitors
inferred← citeshttps://doi.org/10.1111/bcp.12996openalex-snapshot
Cell membranes… and how long drugs may exert beneficial pharmacological activityin vivo
inferred← citeshttps://doi.org/10.1111/bph.12106openalex-snapshot
Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands
inferred← citeshttps://doi.org/10.1111/bph.12683openalex-snapshot
A study of the molecular mechanism of binding kinetics and long residence times of human CCR 5 receptor small molecule allosteric ligands
inferred← citeshttps://doi.org/10.1111/bph.13053openalex-snapshot
‘Partial’ competition of heterobivalent ligand binding may be mistaken for allosteric interactions: a comparison of different target interaction models
inferred← citeshttps://doi.org/10.1111/bph.13445openalex-snapshot
On the different experimental manifestations of two‐state ‘induced‐fit’ binding of drugs to their cellular targets
inferred← citeshttps://doi.org/10.1111/bph.13989openalex-snapshot
Distinct in vivo target occupancy by bivalent‐ and induced‐fit‐like binding drugs
inferred← citeshttps://doi.org/10.1111/bph.70622openalex-snapshot
Receptor kinetics: Binding flux‐based approaches offer complementary insight into how ligand binding evolves with time
inferred← citeshttps://doi.org/10.1111/cbdd.12050openalex-snapshot
Conformational Adaptation Drives Potent, Selective and Durable Inhibition of the Human Protein Methyltransferase DOT1L
inferred← citeshttps://doi.org/10.1124/mol.115.099671openalex-snapshot
Ligand Residence Time at G-protein–Coupled Receptors—Why We Should Take Our Time To Study It
inferred← citeshttps://doi.org/10.1124/molpharm.124.000934openalex-snapshot
Simplified Method for Kinetic and Thermodynamic Screening of Cardiotonic Steroids through the K+-Dependent Phosphatase Activity of Na+/K+-ATPase with Chromogenic pNPP Substrate
inferred← citeshttps://doi.org/10.1126/sciadv.1700014openalex-snapshot
How and when does an anticancer drug leave its binding site?
inferred← citeshttps://doi.org/10.1134/s199075082003004xopenalex-snapshot
Ligand–Receptor Binding Kinetics in Drug Design
inferred← citeshttps://doi.org/10.1177/2472555220985049openalex-snapshot
High-Throughput Quantitative Assay Technologies for Accelerating the Discovery and Optimization of Targeted Protein Degradation Therapeutics
inferred← citeshttps://doi.org/10.1186/1752-0509-7-130openalex-snapshot
RaTrav: a tool for calculating mean first-passage times on biochemical networks
inferred← citeshttps://doi.org/10.1186/s13321-026-01227-0openalex-snapshot
Sequence-based drug-target binding site pre-training enables cryptic pocket detection and improves binding affinity and kinetics prediction
inferred← citeshttps://doi.org/10.1371/journal.pcbi.1003554openalex-snapshot
Towards Structural Systems Pharmacology to Study Complex Diseases and Personalized Medicine
inferred← citeshttps://doi.org/10.14715/cmb/2021.67.1.7openalex-snapshot
Computational hunting of natural active compounds as an alternative for Remdesivir to target RNA-dependent polymerase
inferred← citeshttps://doi.org/10.1517/17460441.2012.687720openalex-snapshot
Radioligand dissociation measurements: potential interference of rebinding and allosteric mechanisms and physiological relevance of the biological model systems
inferred← citeshttps://doi.org/10.1517/17460441.2015.1067196openalex-snapshot
On the ‘micro’-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action
inferred← citeshttps://doi.org/10.1517/17460441.2015.1078308openalex-snapshot
Flexible receptor docking for drug discovery
inferred← citeshttps://doi.org/10.18097/pbmc20206601042openalex-snapshot
Ligand-receptor binding kinetics in drug design
inferred← citeshttps://doi.org/10.18097/pbmcr1536openalex-snapshot
Slow-binding inhibitors of enzymes: kinetic characteristics and pharmacological interest
inferred← citeshttps://doi.org/10.18388/pb.2016_28openalex-snapshot
Adventures in cooperativity
inferred← citeshttps://doi.org/10.21007/etd.cghs.2019.0491openalex-snapshot
Investigation of Narrow Spectrum Targets in Antibacterial Drug Discovery
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1188756/v1openalex-snapshot
A target engagement assay to assess uptake, potency and retention of antibiotics in living bacteria
inferred← citeshttps://doi.org/10.21203/rs.3.rs-655036/v1openalex-snapshot
Comparative Analysis of Small Moleclues and Natural Plants Compounds as Therapeutic Inhibitors Targeting RdRp and Nucleocapsid Proteins of SARS CoV 2: An in Silico Approach
inferred← citeshttps://doi.org/10.21608/fsrt.2023.195650.1086openalex-snapshot
Nanocomposite for Enhancement the Biological Activity of Cu(II)-complex from New Cefotaxime Derivative
inferred← citeshttps://doi.org/10.2174/1871527317666180115162422openalex-snapshot
In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
inferred← citeshttps://doi.org/10.2210/pdb6hk7/pdbopenalex-snapshot
Crystal structure of GSK-3B in complex with pyrazine inhibitor C50
inferred← citeshttps://doi.org/10.22159/ajpcr.2023.v16i10.48095openalex-snapshot
COMPARATIVE ANALYSIS OF SMALL MOLECULES AND NATURAL PLANT COMPOUNDS AS THERAPEUTIC INHIBITORS TARGETING RdRp AND NUCLEOCAPSID PROTEINS OF SARS COV 2: AN IN SILICO APPROACH
inferred← citeshttps://doi.org/10.3389/fmolb.2015.00027openalex-snapshot
Evolution and intelligent design in drug development
inferred← citeshttps://doi.org/10.3389/fphar.2015.00248openalex-snapshot
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach
inferred← citeshttps://doi.org/10.3389/fphar.2018.00766openalex-snapshot
Autoregulation of Acetylcholine Release and Micro-Pharmacodynamic Mechanisms at Neuromuscular Junction: Selective Acetylcholinesterase Inhibitors for Therapy of Myasthenic Syndromes
inferred← citeshttps://doi.org/10.3390/antibiotics10050474openalex-snapshot
High Throughput Virtual Screening and Molecular Dynamics Simulation for Identifying a Putative Inhibitor of Bacterial CTX-M-15
inferred← citeshttps://doi.org/10.3390/chemistry4030067openalex-snapshot
Natural Products as Mcl-1 Inhibitors: A Comparative Study of Experimental and Computational Modelling Data
inferred← citeshttps://doi.org/10.3390/ijms22052582openalex-snapshot
Red-Edge Excitation Shift Spectroscopy (REES): Application to Hidden Bound States of Ligands in Protein–Ligand Complexes
inferred← citeshttps://doi.org/10.3390/molecules26082326openalex-snapshot
Identification of New Mycobacterium tuberculosis Proteasome Inhibitors Using a Knowledge-Based Computational Screening Approach
inferred← citeshttps://doi.org/10.3390/molecules26195878openalex-snapshot
Computational Screening of Natural Compounds for Identification of Potential Anti-Cancer Agents Targeting MCM7 Protein
inferred← citeshttps://doi.org/10.3390/molecules27155042openalex-snapshot
Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression
inferred← citeshttps://doi.org/10.4155/fmc-2016-0183openalex-snapshot
Drug–Target Interaction Kinetics: Underutilized in Drug Optimization?
inferred← citeshttps://doi.org/10.4155/fmc.13.94openalex-snapshot
Resistance Mechanism to an Uncompetitive Inhibitor of a Single-Substrate, Single-Product Enzyme: A Study of Helicobacter Pylori Glutamate Racemase
inferred← citeshttps://doi.org/10.4155/fmc.15.63openalex-snapshot
The Impact of Binding Thermodynamics on Medicinal Chemistry Optimizations
inferred← citeshttps://doi.org/10.4155/fmc.16.9openalex-snapshot
Advanced Molecular Dynamics Simulation Methods for Kinase Drug Discovery
inferred← citeshttps://doi.org/10.4314/tjpr.v19i5.20openalex-snapshot
Molecular interaction of 4-amino-N’-(benzoyloxy)-N-(2,4- dimethylphenyl)-1,2,5-oxadiazole-3-carboximidamide with the methotrexate binding site of human DHFR, and its implication in rheumatoid arthritis
inferred← citeshttps://doi.org/10.64898/2025.12.10.693538openalex-snapshot
Ehrlich occupancy time: Beyond k off to a complete residence time framework
inferred← citeshttps://doi.org/10.70675/1d581f29z4cb3z4657z941ezb57faa759067openalex-snapshot
Prédiction des constantes cinétiques de complexes protéine-ligand
inferred← citeshttps://doi.org/10.7287/peerj.2088v0.1/reviews/1openalex-snapshot
Peer Review #1 of "An explicit-solvent conformation search method using open software (v0.1)"
inferred← citeshttps://doi.org/10.7287/peerj.2088v0.1/reviews/2openalex-snapshot
Peer Review #2 of "An explicit-solvent conformation search method using open software (v0.1)"
inferred← citeshttps://doi.org/10.7717/peerj.2088openalex-snapshot
An explicit-solvent conformation search method using open software
inferred← citeshttps://doi.org/10.9734/jpri/2020/v32i2930880openalex-snapshot
Computational Exploration of Potential Polo-Like Kinase 1 Inhibitors as New Chemotherapeutic Agents
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.